Exploring CAR T-cell therapy for aggressive follicular lymphoma CAR T-cell therapy is an effective treatment for aggressive subtypes of follicular lymphoma, according to a clinical trial published in Nature Medicine. Jul 18, 2024 0 13
Study identifies unpredicted immune responses to adenoviral COVID-19 vaccines Researchers from the University of Liverpool's Center for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines. Jul 18, 2024 0 17
Researchers develop new technique for diagnosing disorders of sex development Disorders/differences of sex development (DSD) are difficult to diagnose because of the multiple phenotypes and genes involved, but a new technique developed at Hudson Institute of Medical Research is set to change all that. Jul 18, 2024 0 4
Computational neuroscientists show how astrocytes increase flexible learning Star-shaped glial cells, so-called astrocytes, are more than just a supporting cell of the brain. They are actively involved in learning processes and interact with nerve cells. But what exactly is it that astrocytes do? Jul 18, 2024 0 76
Finland is offering farmworkers bird flu shots: Some experts say the US should, too As bird flu spreads among dairy cattle in the U.S., veterinarians and researchers have taken note of Finland's move to vaccinate farmworkers at risk of infection. They wonder why their government doesn't do the same. Jul 18, 2024 0 0
Keeping kids safe outside during summer play Summer vacation for kids is well underway. Finding activities to keep the kids busy and destinations to visit can be on many parents' list. There is one place Mayo Clinic's Dr. Steven Maher hopes they don't have to visit—and ... Jul 18, 2024 0 0
Study suggests disparities in post-acute stroke care depend on insurance status Insurance-dependent racial and ethnic disparities and regional variations are seen in post-acute service utilization after stroke, according to a study published online July 17 in Neurology: Clinical Practice. Jul 18, 2024 0 0
Risankizumab found to be noninferior, superior to ustekinumab for Crohn's disease For patients with moderate-to-severe Crohn's disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission at week 48, according to a study published in the ... Jul 18, 2024 0 2
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma In a report published in Nature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospital, the University of Manitoba and collaborating institutions have revealed an unexpected way in which the protein ... Jul 18, 2024 0 35
Naturally occurring peptide could serve as a novel protective agent for 'inflammaging' A naturally occurring peptide called PEPITEM could potentially rejuvenate the immune response in older individuals and protect against "inflammaging," which is widely believed to be the root cause of many age-related diseases. Jul 18, 2024 0 140